Tesamorelin

Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), a naturally occurring peptide produced by the hypothalamus that signals the pituitary gland to release growth hormone. It was developed to closely mimic the body's natural GHRH while offering greater stability, making it an important compound for both clinical and laboratory research. Due to its unique mechanism of action, Tesamorelin has been extensively studied in research involving metabolism, body composition, endocrine function, and healthy aging.

Areas of Research

Researchers have investigated Tesamorelin in laboratory and clinical studies for its potential role in:

• Growth hormone and IGF-1 signaling

• Body composition and visceral adipose tissue research

• Metabolic health and insulin signaling

• Liver and hepatic fat research

• Healthy aging and endocrine function

• Cognitive and neurological research

• Cellular metabolism and energy regulation

  
  

Mechanism of Interest

Tesamorelin binds to GHRH receptors located on pituitary somatotroph cells, stimulating the body's natural release of growth hormone. Unlike administering growth hormone directly, Tesamorelin works by activating the body's own physiological growth hormone pathway, resulting in pulsatile growth hormone secretion and increased production of insulin-like growth factor-1 (IGF-1). Researchers continue to study how these mechanisms influence body composition, metabolic function, and tissue biology.